Real-world data confirms limited efficacy of dual anti-PD-1 and CTLA-4 immune checkpoint blockade in acral lentiginous melanoma.
The British journal of dermatology
| Authors | |
| Year of Publication | 2024
|
| Journal | The British journal of dermatology
|
| Date Published | 11/2024
|
| ISSN | 1365-2133
|
| DOI | 10.1093/bjd/ljae445
|
| PubMed ID | 39545493
|
| Links |